Allows Medical marijuana?: Yes
Allows Adult-Use marijuana?: No
2018 Medical Sales : $10,000,000
2022 Projected Medical Sales : $12,000,000
2018 Adult Use Sales : N/A
2022 Projected Adult Use Sales : $67,000,000.00
Noteworthy Information: Delaware has a small medical dispensary system with required vertical integration (meaning that dispensaries must grow everything they sell themselves). Delaware has some of the best protections for patients in the country, which apply to employers, property owners, schools, and medical professionals. A bill that would add glaucoma, chronic debilitating migraines, pediatric autism spectrum disorder, and pediatric sensory processing disorder is headed to Governor John Carney for action.
Is there a Regulatory Structure? (State Agency): Yes (Delaware Health and Social Services, Division of Public Health, Office of Medical Marijuana)
# of Dispensaries Allowed (# issued): Called "Compassion Centers"
3 allowed (3 issued)
# of Cultivations Allowed (# issued): encompassed by "compassion centers"
# of Manufacturers Allowed (# issued): encompassed by "compassion centers"
# of Testing labs Allowed (# issued): The state entered a contract with AgroLab Organics.
Geographic Distribution of Licenses: N/A
Compassion Center Application Fee= $5,000
Compassion Center Renewal Application Fee= $40,000
Compassion Center Certificate Fee= $40,000
Yes. All principal officers, board members, agents, volunteers, or employees of a compassion center must be residents of Delaware.
Vertical Integration Allowed, Required or Prohibited:
Allowed (It's currently the default since there is only one compassion center in DE)
Medical Marijuana Qualifying Patient Conditions:
Positive status for Human Immunodeficiency Virus (HIV Positive)
Acquired Immune Deficiency Syndrome (AIDS)
Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig’s Disease)
Agitation of Alzheimer’s Disease
Post-Traumatic Stress Disorder (PTSD)
Autism with aggressive behavior
A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following;
- Cachexia or Wasting Syndrome
- Severe debilitating pain that has not responded to previously prescribed medication or surgical measure for more than three months, or for which other treatment options produced serious side effects.
- Intractable Nausea
- Severe and persistent muscle spasms, including but not limited to those characteristic of Multiple Sclerosis.
New Leaf Cannabis Consulting can help you achieve cannabis licensure in Delaware.
The team at New Leaf Cannabis Consulting has assisted cannabis businesses launch successfully throughout the United States. Team New Leaf are high level professionals who are also veterans of this industry: We know what it takes to take you step by step through the licensing process even when regulatory details are unclear.
To learn more or get started, contact us today. We look forward to helping your cannabis business take off in Delaware.
NEW LEAF CANNABIS BUSINESS NEWS
State By State Licensing Information
Legality of cannabis in the United States
Leary v. United States (1969)
Ravin v. State (1975)
Conant v. McCaffrey (2000)
Gonzales v. Raich (2005)
Moncrieffe v. Holder (2013)